|
| |
V.I. Technologies IncorporatedV.I. Technologies is a leading developer of a broadportfolio of blood products and systems which use its proprietary pathogen
inactivation technologies. The Company's technologies are intended to address the risks of viral, bacterial and other pathogen contamination in blood products, including plasma, plasma derivatives, red blood cells and platelets. Viral inactivation processes have the potential to eliminate viruses that are enveloped by lipid membranes such as
hepatitis B virus ("HBV"), hepatitis C virus ("HCV") and HIV, the virus that
causes AIDS, and non-enveloped viruses such as hepatitis A virus ("HAV") and
parvovirus and other known and unknown pathogens.
| Contact Details: |
| 134 Coolidge Avenue |
| Watertown |
| MA |
| 02472 |
| United States of America |
| Tel: | (617) 926-1551 |
| Fax: | |
| Email: | info@vitechnologies.com |
|
Loading...
|
Recent Publications by V.I. Technologies Incorporated: |  |
Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents.
BACKGROUND: Cytomegalovirus (CMV) is transmitted by transfusion of... | 18th October, 2006
| V.I. Technologies, Inc., Watertown, Massachusetts, USA.
| Transfusion. 2006 Sep;46(9):1580-8.
DOI Direct Link |
Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.
BACKGROUND AND OBJECTIVES: The risk of transfusion-transmitted bacterial... | 30th March, 2005
| V. I. Technologies, Inc., Watertown, MA 02472, USA.
| Vox Sang. 2004 Oct;87(3):143-9.
DOI Direct Link |
Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110.
BACKGROUND AND OBJECTIVES: Two different leucocyte-inactivation... | 14th October, 2004
| V. I. Technologies, Inc., Watertown, MA 02465, USA.
| Vox Sang. 2004 Jul;87(1):1-9.
DOI Direct Link |
Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry.
BACKGROUND: The transmission of parasites, including Babesia, plasmodia,... | 3rd June, 2004
| V.I. Technologies, Inc., Watertown, Massachusetts 02472, USA.
| Transfusion. 2004 May;44(5):731-8.
DOI Direct Link |
Inactivation of mycoplasma species in blood by INACTINE PEN110 process.
BACKGROUND: Mycoplasmas have been associated with multiple acute and... | 24th March, 2004
| V. I. Technologies, Inc., Watertown, Massachusetts 02472, USA.
| Transfusion. 2004 Feb;44(2):286-93.
|
→View more V.I. Technologies Incorporated research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 359 times since April 2007, the link to the organisation's website has been followed 0 times Recent Search Terms used to find this page: V.I. Technologies | V I Technologies Inc. | the winding road from ideas to income nature | t | vi tecnologies watertown ma | V.I. Technologies | vi technologies | V.I. Technologies | Vi Technologies | VI Technology blood products | . Search for more companies in Watertown Search for more companies in MA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for V.I. Technologies Incorporated |